ANDREA KOCSIS ET AL: "Selective Inhibition of the Lectin Pathway of Complement with Phage Display Selected Peptides against Mannose-Binding Lectin-Associated Serine Protease (MASP)-1 and -2: Significant Contribution of MASP-1 to Lectin Pathway Activation", THE JOURNAL OF IMMUNO, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 185, 1 January 2010 (2010-01-01), pages 4169-4178, XP007915332, ISSN: 0022-1767, DOI: 10.4049/JIMMUNOL.1001819 [retrieved on 2010-09-03] (B1)

DEGN SØREN E ET AL: "Biological variations of MASP-3 and MAp44, two splice products of theMASP1gene involved in regulation of the complement system", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 361, no. 1, 29 July 2010 (2010-07-29) , pages 37-50, XP029816803, ISSN: 0022-1759, DOI: 10.1016/J.JIM.2010.07.006 (B1)

H. JIANG ET AL: "Complement 1 Inhibitor Is a Regulator of the Alternative Complement Pathway", THE JOURNAL OF EXPERIMENTAL MEDICINE, vol. 194, no. 11, 3 December 2001 (2001-12-03), pages 1609-1616, XP055246972, US ISSN: 0022-1007, DOI: 10.1084/jem.194.11.1609 (B1)

M. FRIDKIS-HARELI ET AL: "Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases", BLOOD, vol. 118, no. 17, 27 October 2011 (2011-10-27), pages 4705-4713, XP055072079, ISSN: 0006-4971, DOI: 10.1182/blood-2011-06-359646 (B1)

NIRMAL K BANDA ET AL: "Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 49, no. 1, 27 August 2011 (2011-08-27), pages 281-289, XP028328168, ISSN: 0161-5890, DOI: 10.1016/J.MOLIMM.2011.08.021 [retrieved on 2011-09-05] (B1)

WONG N K H ET AL: "ACTIVITIES OF THE MBL-ASSOCIATED SERINE PROTEASES (MASPS) AND THEIR REGULATION BY NATURAL INHIBITORS", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 36, no. 13/14, 1 January 1999 (1999-01-01), pages 853-861, XP001037853, ISSN: 0161-5890, DOI: 10.1016/S0161-5890(99)00106-6 (B1)

S. ZUNDEL ET AL: "Characterization of Recombinant Mannan-Binding Lectin-Associated Serine Protease (MASP)-3 Suggests an Activation Mechanism Different from That of MASP-1 and MASP-2", THE JOURNAL OF IMMUNOLOGY, vol. 172, no. 7, 19 March 2004 (2004-03-19), pages 4342-4350, XP055246991, US ISSN: 0022-1767, DOI: 10.4049/jimmunol.172.7.4342 (B1)

US-A1- 2011 311 549 (B1)

WO-A1-2011/057158 (B1)

WO-A2-01/40451 (B1)

RISITANO A M ET AL: "The human complement receptor type 2/factor H fusion protein TT30, an alternative pathway specific complement inhibitor, prevents hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria by membrane-targeting of factor H activity", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 47, no. 13, 1 August 2010 (2010-08-01), page 2215, XP027120165, ISSN: 0161-5890 [retrieved on 2010-07-03] (B1)